Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Taiwan · Delayed Price · Currency is TWD

15.85

+0.25 (1.60%)

Jul 30, 2026, 12:38 PM CST

-18.72% (1Y)

Market Cap	871.59M -21.8%
Revenue (ttm)	843.26M -5.8%
Net Income	-34.13M
EPS	-0.61
Shares Out	55.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,200
Open	15.70
Previous Close	15.60
Day's Range	15.70 - 15.85
52-Week Range	15.50 - 30.50
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Anxo Pharmaceutical

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroentero... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2003

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 6677

Full Company Profile

Financial Performance

In 2025, Anxo Pharmaceutical's revenue was 843.26 million, a decrease of -5.81% compared to the previous year's 895.32 million. Losses were -34.13 million, -40.34% less than in 2024.

Financial Statements